Elan Reports Second Quarter 2008 Financial Results DUBLIN, Ireland--(BUSINESS WIRE)--Elan Corporation, plc today announced its second quarter 2008 financial results and provided a business update.Commenting on Elans business, Kelly Martin, Elans president and chief executive officer, said...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati - Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also named Vice Chair of the...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati Author : NY-ACORDA-THERAPEUTICS Category : Press Release News Alerts by Email ( click here ) Press Release News | Home HAWTHORNE, N.Y.- (Business Wire) Acorda Therapeutics, Inc.
(NASDAQ: ACOR) today announced President and CEO Ron Cohen...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati - Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also named Vice Chair of the...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati , 7:00 AM EST News source: Business Wire Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati -- Also Named Vice Chair of Emerging Companies Section -- Company Website: http:www.acorda.comHAWTHORNE, N.Y.-- (Business Wire) Acorda Therapeutics, Inc.
(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati Acorda Therapeutics, Inc.(ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also named Vice Chair of the Emerging...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati Acorda Therapeutics, (News) Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also named Vice Chair of the...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was also named Vice Chair of the Emerging...
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organizati HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc.(NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D.
has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO).
Cohen was...
